303 related articles for article (PubMed ID: 32598367)
1. N-glycomic profiling of colorectal cancer according to tumor stage and location.
Holm M; Nummela P; Heiskanen A; Satomaa T; Kaprio T; Mustonen H; Ristimäki A; Haglund C
PLoS One; 2020; 15(6):e0234989. PubMed ID: 32598367
[TBL] [Abstract][Full Text] [Related]
2. N-glycosylation Profiling of Colorectal Cancer Cell Lines Reveals Association of Fucosylation with Differentiation and Caudal Type Homebox 1 (CDX1)/Villin mRNA Expression.
Holst S; Deuss AJ; van Pelt GW; van Vliet SJ; Garcia-Vallejo JJ; Koeleman CA; Deelder AM; Mesker WE; Tollenaar RA; Rombouts Y; Wuhrer M
Mol Cell Proteomics; 2016 Jan; 15(1):124-40. PubMed ID: 26537799
[TBL] [Abstract][Full Text] [Related]
3. N-glycomic profiling as a tool to separate rectal adenomas from carcinomas.
Kaprio T; Satomaa T; Heiskanen A; Hokke CH; Deelder AM; Mustonen H; Hagström J; Carpen O; Saarinen J; Haglund C
Mol Cell Proteomics; 2015 Feb; 14(2):277-88. PubMed ID: 25452313
[TBL] [Abstract][Full Text] [Related]
4. N-Glycomic Profiling of Pheochromocytomas and Paragangliomas Separates Metastatic and Nonmetastatic Disease.
Leijon H; Kaprio T; Heiskanen A; Satomaa T; Hiltunen JO; Miettinen MM; Arola J; Haglund C
J Clin Endocrinol Metab; 2017 Nov; 102(11):3990-4000. PubMed ID: 28938401
[TBL] [Abstract][Full Text] [Related]
5. Comparison of N-glycans expressed in tumor tissues with those expressed in adjacent non-tumor tissues of colorectal cancer patients
.
Ji E
Int J Clin Pharmacol Ther; 2019 May; 57(5):249-258. PubMed ID: 30738496
[TBL] [Abstract][Full Text] [Related]
6. Mass spectrometric profiling reveals association of N-glycan patterns with epithelial ovarian cancer progression.
Chen H; Deng Z; Huang C; Wu H; Zhao X; Li Y
Tumour Biol; 2017 Jul; 39(7):1010428317716249. PubMed ID: 28681696
[TBL] [Abstract][Full Text] [Related]
7. Identifying N-Glycan Biomarkers in Colorectal Cancer by Mass Spectrometry.
Sethi MK; Hancock WS; Fanayan S
Acc Chem Res; 2016 Oct; 49(10):2099-2106. PubMed ID: 27653471
[TBL] [Abstract][Full Text] [Related]
8. N-glycan MALDI Imaging Mass Spectrometry on Formalin-Fixed Paraffin-Embedded Tissue Enables the Delineation of Ovarian Cancer Tissues.
Everest-Dass AV; Briggs MT; Kaur G; Oehler MK; Hoffmann P; Packer NH
Mol Cell Proteomics; 2016 Sep; 15(9):3003-16. PubMed ID: 27412689
[TBL] [Abstract][Full Text] [Related]
9. N-glycosylation of colorectal cancer tissues: a liquid chromatography and mass spectrometry-based investigation.
Balog CI; Stavenhagen K; Fung WL; Koeleman CA; McDonnell LA; Verhoeven A; Mesker WE; Tollenaar RA; Deelder AM; Wuhrer M
Mol Cell Proteomics; 2012 Sep; 11(9):571-85. PubMed ID: 22573871
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer diagnosis and prognosis through quantitative measurements of serum glycan profiles.
Kyselova Z; Mechref Y; Kang P; Goetz JA; Dobrolecki LE; Sledge GW; Schnaper L; Hickey RJ; Malkas LH; Novotny MV
Clin Chem; 2008 Jul; 54(7):1166-75. PubMed ID: 18487288
[TBL] [Abstract][Full Text] [Related]
11. Sidedness Matters: Surrogate Biomarkers Prognosticate Colorectal Cancer upon Anatomic Location.
Ben-Aharon I; Goshen-Lago T; Sternschuss M; Morgenstern S; Geva R; Beny A; Dror Y; Steiner M; Hubert A; Idelevich E; Shulman K; Mishaeli M; Man S; Liebermann N; Soussan-Gutman L; Brenner B
Oncologist; 2019 Aug; 24(8):e696-e701. PubMed ID: 30755502
[TBL] [Abstract][Full Text] [Related]
12. In-depth N-glycome profiling of paired colorectal cancer and non-tumorigenic tissues reveals cancer-, stage- and EGFR-specific protein N-glycosylation.
Sethi MK; Kim H; Park CK; Baker MS; Paik YK; Packer NH; Hancock WS; Fanayan S; Thaysen-Andersen M
Glycobiology; 2015 Oct; 25(10):1064-78. PubMed ID: 26085185
[TBL] [Abstract][Full Text] [Related]
13. Dynamic alterations in serum IgG N-glycan profiles in the development of colitis-associated colon Cancer in mouse model.
Gu Y; Han J; Liu X; Pan Y; Xu X; Sha J; Ren S; Gu J
Biochim Biophys Acta Gen Subj; 2020 Oct; 1864(10):129668. PubMed ID: 32553689
[TBL] [Abstract][Full Text] [Related]
14. In-Depth Analysis of the
Wang D; Kuzyk V; Madunić K; Zhang T; Mayboroda OA; Wuhrer M; Lageveen-Kammeijer GSM
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902272
[TBL] [Abstract][Full Text] [Related]
15. Mass spectrometry analysis reveals aberrant N-glycans in colorectal cancer tissues.
Zhang D; Xie Q; Wang Q; Wang Y; Miao J; Li L; Zhang T; Cao X; Li Y
Glycobiology; 2019 May; 29(5):372-384. PubMed ID: 30698702
[TBL] [Abstract][Full Text] [Related]
16. N-Glycomic Signature of Stage II Colorectal Cancer and Its Association With the Tumor Microenvironment.
Boyaval F; van Zeijl R; Dalebout H; Holst S; van Pelt G; Fariña-Sarasqueta A; Mesker W; Tollenaar R; Morreau H; Wuhrer M; Heijs B
Mol Cell Proteomics; 2021; 20():100057. PubMed ID: 33581319
[TBL] [Abstract][Full Text] [Related]
17. Colorectal cancer cell lines show striking diversity of their O-glycome reflecting the cellular differentiation phenotype.
Madunić K; Zhang T; Mayboroda OA; Holst S; Stavenhagen K; Jin C; Karlsson NG; Lageveen-Kammeijer GSM; Wuhrer M
Cell Mol Life Sci; 2021 Jan; 78(1):337-350. PubMed ID: 32236654
[TBL] [Abstract][Full Text] [Related]
18. Providing Bionic Glycome as internal standards by glycan reducing and isotope labeling for reliable and simple quantitation of N-glycome based on MALDI- MS.
Qin W; Zhang Z; Qin R; Han J; Zhao R; Gu Y; Pan Y; Gu J; Ren S
Anal Chim Acta; 2019 Nov; 1081():112-119. PubMed ID: 31446948
[TBL] [Abstract][Full Text] [Related]
19. The role of N-glycans in colorectal cancer progression: potential biomarkers and therapeutic applications.
de Freitas Junior JC; Morgado-Díaz JA
Oncotarget; 2016 Apr; 7(15):19395-413. PubMed ID: 26539643
[TBL] [Abstract][Full Text] [Related]
20. Mass Spectrometry-Based N-Glycomics of Colorectal Cancer.
Sethi MK; Fanayan S
Int J Mol Sci; 2015 Dec; 16(12):29278-304. PubMed ID: 26690136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
